Author: Burbelo, Peter D.; Chaturvedi, Adrija; Notkins, Abner L.; Gunti, Sreenivasulu
Title: Luciferase-Based Detection of Antibodies for the Diagnosis of HPV-Associated Head and Neck Squamous Cell Carcinoma Document date: 2019_8_6
ID: 06glboqq_19
Snippet: There is also great interest in rapid point of care tests for infection, cancer, and autoimmunity [32] . The most common POC directed at diagnostic antibodies are based on lateral flow and microfluidic devices. One recent study showed that a microfluidic device coupled with immunoassay detected HPV-16 E6 antibodies with moderate diagnostic sensitivity and specificity but required at least an hour for processing [10] . Here, the one-minute LIPSTIC.....
Document: There is also great interest in rapid point of care tests for infection, cancer, and autoimmunity [32] . The most common POC directed at diagnostic antibodies are based on lateral flow and microfluidic devices. One recent study showed that a microfluidic device coupled with immunoassay detected HPV-16 E6 antibodies with moderate diagnostic sensitivity and specificity but required at least an hour for processing [10] . Here, the one-minute LIPSTICKS assay performed quite well to detect HPV-16 E6 antibodies associated with HNSCC. While some of the HNSCC subjects showed relatively dramatic differences between the negative and positive samples, other subjects were less easily detected as seropositive and fell near the cut-off value and one sample was negative. We anticipate that further improvements in the E6 HPV-16 LIPSTICK assay related to antigen design and assay standardization will further enhance test performance. One limitation of our study was the relatively small cohort that was tested. Exploring whether LIPSTICKS can detect HPV-associated HNSCC in a larger well-characterized cohort is warranted.
Search related documents:
Co phrase search for related documents- antigen design and diagnostic antibody: 1, 2
- antigen design and diagnostic sensitivity: 1
- antigen design and great interest: 1
- antigen design and lateral flow: 1
- assay standardization and lateral flow: 1
- care test and cut value: 1
- care test and diagnostic antibody: 1, 2, 3, 4
- care test and diagnostic sensitivity: 1, 2, 3, 4, 5, 6, 7, 8
- care test and immunoassay detect: 1
- care test and lateral flow: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- characterize cohort and large characterize cohort: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- cut value and diagnostic antibody: 1, 2
- cut value and diagnostic sensitivity: 1, 2, 3, 4, 5, 6, 7
- cut value and great interest: 1, 2
- cut value and immunoassay detect: 1, 2
- cut value and lateral flow: 1, 2, 3
- diagnostic antibody and lateral flow: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- diagnostic sensitivity and immunoassay detect: 1, 2, 3
- diagnostic sensitivity and lateral flow: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date